July 25, 2023
GE HealthCare, which officially spun off early this year, announced it is raising its full-year guidance range amid increased demand and ease of supply chain woes.
The company reported $418 million in net income in the second quarter compared with $485 million in the prior-year period and revenue of $4.8 billion, a growth of 7% year-over-year and a 9% organic revenue growth.
The health tech...
May 31, 2023
GE HealthCare announced it received FDA 510(k) clearance for its Precision DL deep learning image processing software.
Precision DL utilizes deep learning, a subset of AI and machine learning, to improve image quality on the company's PET/CT, Omni Legend, and allows for faster scanning time and improved small lesion detection. The software is the company's latest addition to its Effortless Recon...
April 25, 2023
GE HealthCare's stock slipped Tuesday morning even as the health technology giant beat earnings estimates during its first full quarter as an independent company.
The company, which officially spun off early this year, reported $372 million in net income in the first quarter compared with $389 million in the prior-year period.
The health tech giant reported revenue of $4.7 billion, an 8% increase...
February 9, 2023
GE HealthCare announced Thursday it had signed an agreement to acquire Caption Health, maker of AI-enabled ultrasound guidance software.
The deal marks the newly independent company's second acquisition announcement since it completed its spin-off a month ago. Shortly after the newly spun-off GE HealthCare debuted on Nasdaq, the company revealed it had entered into an agreement to buy French...
January 12, 2023
GE HealthCare announced it had entered into an agreement to acquire French company IMACTIS, developer of computed tomography (CT) interventional guidance technology.
The deal marks the newly independent company's first acquisition. GE completed the spin-off of its healthcare unit last week. Financial details for the transaction weren't disclosed, but GE HealthCare said it plans to fund the...
January 6, 2023
GE HealthCare named Dr. Taha Kass-Hout as the newly spun-out company's first chief technology officer.
Kass-Hout comes to GE from Amazon Web Services, where he served as vice president of machine learning and chief medical officer. He was also chief health informatics officer at the FDA for two terms during the Obama Administration and director of information science and informatics for the CDC...
January 4, 2023
GE announced on Wednesday it had completed the spinoff of its healthcare unit.
GE HealthCare began trading on Nasdaq as an independent company under the ticker symbol GEHC. The spinoff, which was first announced in 2021, is part of a larger effort to divide the 130-year-old industrial giant into three separate companies. It plans to complete the separation of GE Aerospace and GE Vernova, which is...
November 29, 2022
GE Heathcare and MediView XR, a med-tech company that leverages augmented reality, announced their collaboration to co-develop the OmnifyXR Interventional Suite System. It will combine medical imaging and mixed-reality solutions to assist physicians and their care teams.
The collaboration will pair GE's imaging technologies with MediView's augmented reality and surgical navigation expertise to...
October 19, 2022
GE Healthcare and AMC Health are partnering to offer remote patient monitoring technology to patients after they've been discharged from the hospital.
The collaboration will pair GE's clinical monitoring in the hospital with AMC's home-based tools, allowing providers to keep an eye on patients with chronic conditions or those recovering from a hospital stay, according to both companies.
February 14, 2022
Baheya Foundation – an Egyptian non-profit that provides breast cancer treatment free of charge – has partnered with GE Healthcare to explore the use of artificial intelligence (AI) to improve outcomes in patients.
According to GE Healthcare, it is working with the foundation and its hospital to “develop and validate the use of AI to assess and predict the response of neoadjuvant therapy” in...